Clinical Trials Browser

Phase 1/2 × azeliragon × Gastrointestinal × Clear all

NCT05766748 2024-06-14

Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms